BCL2 and esophageal squamous cell carcinoma: Inactivation of Stat3-Bcl-2 pathway contributes to metformin-induced growth inhibition of esophageal squamous cell carcinoma (ESCC) by facilitating crosstalk between apoptosis and autophagy32.